Originally posted by dannydesloover
View Post
Unconfigured Ad
Collapse
X
-
Illumina R&D has transitioned away from chip-based systems and is now releasing new sample prep kits recommending the Fragment Analyzer:
http://res.illumina.com/documents/pr...rna-access.pdf
Illumina recently announced Advanced Analytical as an automation partner for their Fragment Analyzer system:
Comment
-
I am also interested in using the QIAxcell for this purpose, could you share some expertize with us?Originally posted by garciad1 View PostWe recently installed a Qiaxcel in our lab, but the training was horrible. Could you tell me what run parameters, marker, etc. you use for running NGS libraries for sizing etc.? I can't seem to find any references for using the system for this purpose. --Thanks!
Comment
-
Can Qiaxcel be used instead of Bioanalyzer for Library QC?
I'm hoping to purchase a MiSEQ in the next few months and wondering whether I need a Bioanalzyer as I already have a Qiaxcel - can you use the Qiaxcel for library QC? Do you have any SOPs for doing this?Originally posted by adaptivegenome View PostI use the Qiaxcel system. It works for me as well as the Bioanalyzer but the sample cost is about 4 times lower. It does use gel capillaries and the array lasts for only 6 months at a time so if you are not a high volume user, it might not be as cost effective as it is for me.
Thanks,
k
Comment
-
I believe the Qiaxcell injects markers independently of sample, so it will deliver size data, but you will need a fluorometer (Qubit) to get accurate concentration measurements. Ionic strength differences between samples and standards impact injection efficiency. Normalization is required to measure concentration.
The Fragment Analyzer offers qualitative kits that inject markers independently of sample like the Qiaxcel. These kits are inexpensive and useful for sizing applications like PCR screening, genotyping, RFLP, microsatellites, etc. They are also useful for relative concentration measurements of peaks within a sample. IDT just published a CRISPER/Cas9 cleavage assay for their gene block products using these kits on the Fragment Analyzer:
To lessen CRISPR’s resistance to high-throughput application, Integrated DNA Technologies introduces fully synthesized sgRNA transcription fragments.
The Fragment Analyzer also has quantitative kits that mix markers with samples like the BioAnalyzer. This enables use of the marker molecules as a normalization factor with reference to the molecules in the ladder as concentration standards. The system is easy to use and reliable with automated gel cycling and parallel analysis (not rapid serial injection). The different Fragment Analyzer quantitative kits work for small Illumina type NGS libraries as well as larger PacBio and nanopore type libraries and genomic DNA that exceed the size range of the BioAnalyzer. Resolution and sensitivity are excellent. Its a solid analytical platform for all kinds of DNA and RNA applications.
Comment
Latest Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
Yesterday, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 02:55 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 02:55 AM
|
||
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
12 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
12 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
24 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
Comment